Secure online questionnaire covering your health, medicines and goals. Upload recent weight/BMI if available.
A UK GP confirms eligibility, agrees a safe starting dose, and sets a tailored titration timeline. If Mounjaro isn’t right for you, we’ll discuss suitable alternatives.
Once approved, we dispense with temperature‑controlled, discreet delivery to your door or arrange clinic collection. Pens include needles; a sharps bin is provided with disposal guidance.
Tirzepatide is a dual incretin receptor agonist that targets GLP‑1 and GIP receptors. Activating these pathways can reduce appetite, slow stomach emptying, and improve post‑meal insulin secretion and glucose control. The combined effect supports a sustained calorie deficit and weight loss when paired with healthy lifestyle changes.
Unlike semaglutide (GLP‑1 only), tirzepatide also acts on the GIP receptor. Some people respond better to one mechanism than the other; we will tailor to your response and tolerability.
Tirzepatide can improve glycaemic control. If used with insulin or sulfonylureas, we will plan for glucose monitoring and may adjust doses to reduce hypoglycaemia risk.
Alcohol doesn’t directly interact, but it can worsen nausea/heartburn, add calories and impair weight loss. If you drink, keep it light and avoid on dose‑increase weeks.
Yes. Use a cool bag/ice pack, carry a doctor’s letter and the leaflet, and keep pens in hand luggage. Avoid freezing/overheating.